Screening of hepatitis E virus infection should be included in the current diagnostic scale for drug-induced liver injury in Japan

Hiroshi Okano, Tatsunori Nakano, Hiroaki Okamoto

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

We compared the clinical features and laboratory data of 13 cases with acute hepatitis E and 61 cases with drug-induced liver injury (DILI) in our hospital. Out of 13 hepatitis E cases, 12 had no history of eating or undercooked raw meat/viscera and remained unknown for the origin and route of hepatitis E virus (HEV) infection. More than half of acute hepatitis E and DILI did not exhibit jaundice during the clinical course. All 13 cases of acute hepatitis E had a high score of ≥5 points by the DDW-J 2004 scale. Without HEV screening, eight cases of acute hepatitis E might have been misdiagnosed as DILI. The DDW-J 2004 scoring scale, current diagnostic scale for DILI, cannot discriminate acute hepatitis E cases from DILI cases because the scoring scale has no support for HEV infection. We propose that HEV-IgA test should be included in the current diagnostic scale for drug-induced liver injury for differential diagnosis of acute HEV infection to provide more accurate diagnosis of DILI in Japan.

Original languageEnglish
Pages (from-to)325-334
Number of pages10
JournalKanzo/Acta Hepatologica Japonica
Volume55
Issue number6
DOIs
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • Hepatology

Fingerprint

Dive into the research topics of 'Screening of hepatitis E virus infection should be included in the current diagnostic scale for drug-induced liver injury in Japan'. Together they form a unique fingerprint.

Cite this